Showing results (5801-5810 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|July 25, 1998
A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancerS Iacobelli, L Irtelli, R Sacco, et al.Anticancer Research|July 25, 1998
The role of surgery in the treatment of primary gastric lymphomaG Lucandri, F Stipa, P L Mingazzini, et al.Anticancer Research|July 25, 1998
Initial TPS serum level as an indicator of relapse and survival in colorectal cancerM Mishaeli, B Klein, E Sadikov, et al.Anticancer Research|August 26, 1998
Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot studyG L Denardo, S J Denardo, D L Kukis, et al.Anticancer Research|August 26, 1998
Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsiesL Matturri, B Biondo, A Cazzullo, et al.Anticancer Research|August 26, 1998
Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumorN Mitsuhashi, K Hayakawa, M Hasegawa, et al.Anticancer Research|August 26, 1998
Relationship between grade of intraductal component of breast cancer within main tumor and extent of intraductal spread in surrounding tissueM Kurosumi, K Suemasu, T Tabei, et al.Anticancer Research|August 26, 1998
Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatinG P Raaphorst, J Mao, H Yang, et al.Anticancer Research|August 26, 1998
In vitro anti-multidrug resistance activities of acyclic and cyclic disulfonamides in murine leukemia cellsS Wakusawa, H Sawanishi, H HayashiAnticancer Research|August 26, 1998
Multidrug resistance related genes and p53 expression in human non small cell lung cancerS Galimberti, A Marchetti, F Buttitta, et al.Pageof 2,589